Sun Pharma Advanced Research’s net loss widens to Rs 83 crore in Q2

10 Nov 2020 Evaluate

Sun Pharma Advanced Research (SPARC) has reported results for second quarter ended September 30, 2020.

The company has reported net loss of Rs 83.49 crore for the quarter under review as against net loss of Rs 63.16 crore for the same quarter in the previous year. However, total income of the company increased 5.19% at Rs 20.46 crore for Q2FY21 as compared Rs 19.45 crore for the corresponding quarter previous year.

SPARC is an international pharmaceutical company engaged in research and development of drugs and delivery systems.

Sun Pharma Adv. Res Share Price

204.40 14.00 (7.35%)
22-Nov-2024 16:59 View Price Chart
Peers
Company Name CMP
Syngene Internation. 869.40
Sagility India 28.03
AGS Transact Tech 79.99
Just Dial 1073.50
Krystal Integrated 643.20
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.